Ellen Cahir-McFarland

Company: Abata Therapeutics

Job title: CSO

Seminars:

Advancing Early-Stage TCR Targeted Treg Cell Therapy Programs for Autoimmune Diseases with Substantial Unmet Need 12:00 pm

Developing TCR-Treg therapies for tissue-specific autoimmune diseases including multiple sclerosis and type 1 diabetes Stopping immune-mediated destruction, restore homeostasis, and promote repair in effected tissues Advancing our programs with plans to initiate its first clinical study in 2024Read more

day: Conference Day One